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I slet transplantation represents a potential treatment for insulin-dependent diabetes. Development and application of this technique is hampered by the limited availability of human donor tissue. In vitro expansion of human p-cells may provide an adequate source for p-cell grafts. So far, attempts to expand adult rodent p-cells have been unsuccessful. In different experimental conditions, this cell type has a low rate of replication both in vivo and in vitro (1, 2) . Nutrients and growth factors can stimulate fetal or neonatal P-cell replication, but most adult p-cells appear unresponsive to growth factor stimulation in vitro (1) . In vivo, the main mechanism leading to increased p-cell numbers appears to involve neogenesis from ductal progenitor cells (2, 3) . Human p-cells exhibit a very low proliferative activity both during fetal development (9) and in adult life (4) . According to a recent report, the proliferation of fetal human p-cells can be stimulated by hepatocyte growth factor (HGF) (5) . Furthermore, also adult human p-cells appear to proliferate when cultured in the presence of HGF and an extracellular matrix prepared from rat 804G cells (6) . The present study compares the mitogenic effect of this condition on the different cell types that compose a human islet preparation. Our findings contradict the conclusion of Hayek et al. (6) , but indicate, instead, that HGF stimulates the proliferation of adult pancreatic duct cells.
RESEARCH DESIGN AND METHODS
Islet isolation and culture. Human islets from ten heart-beating organ donors were isolated at the Central Unit of p-cell Transplant, Medical Campus, Vrije Universiteit, Brussels. The mean age of the organ donors was 41 ± 5 years (means ± SE [range 19-64]) and the mean organ preservation time 11 ± 2 h (range 4-20 h). Pancreases were processed by ductal distension with collagenase, gentle dissociation, and Ficoll gradient purification of islets. Islet-enriched fractions were cultured in serum-free Ham's F10 medium (Gibco, Life Technologies, Paisley, Scotland, U.K.) with 7.5 mmol/1 glucose, 1% bovine serum albumin, 0.075 ing penicillin/ml, 0.1 mg streptomycin/ml, and 2 mmol/1 glutamine (7). After 4-16 days of culture, these preparations contained <5% damaged cells, no acinar cells, 25 ± 5% ductal cells, 63 ± 5% insulin-positive cells, and 12 ± 2% glucagon-positive cells. They were recovered within this culture period and distributed into 35-mm dishes for either suspension culture or monolayer culture on 804G matrix (6) for a subsequent 1-7 days culture in RPMI1640 medium (Gibco, Life Technologies) with 5.5 mmol/1 or 11.1 mmol/1 glucose, 10% pooled AB human serum (BioWhittaker, Walkersville, MD, or Finnish Red Cross, Helsinki, Finland), and antibiotics (0.075 mg penicillin/ml and 0.1 mg streptomycin/ml) with or without human recombinant HGF (10-15 ng/ml) (Sigma, St. Louis, MO, or R&D Systems, Abingdon, U.K.). Medium was replaced every 2 days. Parallel samples were carried in 24-well plates (Falcon, Becton Dickinson, Lincoln Park, NJ) and on Thermanox coverslips (Nunc, Naperville, IL) coated with the 804G matrix.
Proliferation assay and immunocytochemistry. During the last hour or 24 h of culture, 5-bromo-2'-deoxyuridine (BrdU) (Sigma) 0.1 mmol/1 was added and the preparations were then removed with trypsin/EDTA (Gibco) or dispase (Boehringer Mannheim, Mannheim, Germany), washed, fixed overnight in 4% neutral-buffered formaldehyde, and embedded in paraffin. Immunohistochemical staining of sections was performed by the streptavidin-biotin method. For analysis of BrdU and cytokeratin-19 staining, sections were pretreated with trypsin to retrieve antigenicity (8, 9) . For double-staining, peroxidase/diaminobenzidine (brown color) and alkaline phosphatase/New Fuchsin (red color) were used for BrdU and cytokeratin 19 or insulin, respectively. Negative controls consisted of omission of the primary antibody. Electron microscopy and in situ hybridization for insulin mRNA were performed as previously described (10) . The percent positive cells is presented as a mean ± SE for n independent experiments. Statistical significance of differences was calculated by one-way analysis of variance (ANOVA) and Scheffe test. Antibodies. Monoclonal antibody to cytokeratin 19 was from Dako (Glostrup, Denmark; clone RCK108), monoclonal antibody to cytokeratin 7 from Biogenex (San Ramon, CA), monoclonal antibody to carbohydrate antigen 19-9 from Cis Bio International (Gif-sur-Yvette, France), and monoclonal anti-BrdU from Eurodiagnostics (Apeldoorn, The Netherlands). Polyclonal guinea pig anti-insulin and rabbit anti-glucagon were kindly provided by Dr. C. Van Schravendyk (Diabetes Research Center, Free University Brussels, Belgium), and polyclonal rabbit anticarbonic anhydrase II was a gift from Dr. A.-K. Parkkila (Department of Anatomy, University of Oulu, Finland). Biotinylated secondary antibodies and ABC kits were purchased from Dako.
RESULTS
After 1,2,4, or 7 days of culture on 804G matrix, <0.1% of the insulin-positive cells had incorporated BrdU, while many insulin-negative cells became BrdU + , starting within 48 h and reaching a maximum after 4 days. The decrease in proliferation after 7 days is probably caused by contact inhibition, since the cultures were nearly confluent at this time. The mitogenic effect on the insulin-negative cells was higher in the presence of HGF (Fig. 1) . The BrdLT cells were negative for preproinsulin mRNA in situ hybridization but expressed ductal cell markers such as cytokeratin 19 (Fig. 2B ), cytokeratin 7, carbonic anhydrase-II, and carbohydrate antigen 19-9 (not shown). These four markers have been previously shown to be specifically localized in pancreatic duct cells (9, (11) (12) (13) (14) .
The proliferative activity of the different cell types was assessed by determining the percentages of insulin-positive, glucagon-positive, and cytokeratin 19 + cells that were also positive for BrdU after a 4-day culture in the four selected test conditions: suspension or matrix with and without HGF. Less than 0.1% of the insulin-positive cells and <1% of the glucagon-positive cells were found to be BrdU + , irrespective of the presence of matrix or HGF (Table  1) . On the other hand, 30% of the cytokeratin 19 + cells were BrdlT after culture on matrix plus HGF, which is significantly more than after culture in suspension or on matrix without HGF (Table 1 ). These observations were made after detaching the cell layers from the bottom of the culture dish with dispase. Also, when these preparations were completely dissociated into single cells, no insulin BrdU double-positive cells were detected, but many cells were positive for both BrdU and ductal markers.
Islet cell preparations cultured on matrix plus HGF were found to be organized as bi-or multilayers with the insulin-positive cells frequently covered by a thin layer of cytokeratin 19 + cells. This particular organization could only be discerned in sections ( Fig. 2A-B,E-F) . Consequently, when these preparations are viewed unsectioned from the top or the bottom, they will generate images of BdrU + non-endocrine cells that are superposed on insulin-positive cells , and hence may suggest the presence of cells that seem double-positive for BrdU and insulin (Fig. 2CJD) . At the end of the 24-h culture period with BrdU, the preparations presented couples of adjacent BrdU + cells, suggesting the formation of daughter cells ( Fig. 2A, E) .
DISCUSSION
The present study questions the recent statement that human p-cells proliferate on an extracellular matrix in medium supplemented with HGF (6). This culture condition was indeed found to stimulate the mitotic activity in human islet cell preparations, but the effect was almost exclusively located in the ductal cells, which are consistently associated with isolated human endocrine islet cells (unpublished observations). These ductal cells can be identified by specific markers such as cytokeratin 19, cytokeratin 7, carbonic anhydrase-II, or carbohydrate antigen 19-9 (9, (11) (12) (13) (14) . In sections from detached cell cultures, we noticed the formation of a ductal cell monolayer on top of clusters of insulin-positive cells. This particular arrangement may create false impressions of double-positivity in unsectioned material that is viewed from the top or the bottom. We assume that this phenomenon may have caused an erroneous interpretation on the identity of the BrdU + cells in the study of Hayek et al. (6) . Double immunocytochemistry on sectioned material clearly indicated that virtually all BrdU + cells in the matrix plus HGF condition were negative for insulin or glucagon and preproinsulin mRNA, but positive for the ductal cell markers. This was the case in preparations both with a higher (88%) or lower (44%) percentage of endocrine cells at the start of culture. Analysis of the time course of cell-specific proliferation confirmed that only insulin-negative cells proliferated at any time point, thus excluding the possibility that the BrdUlabeled cells would represent transdifferentiated (3-cells.
Stimulation of duct cell proliferation was only significant for the combination of the 804G matrix and HGF. That HGF is a mitogen for human pancreatic epithelial cells has already been reported by Vila et al. (15) . HGF-induced proliferation of fetal human (B-cells has also been clearly demonstrated (5) . In the present study, we failed to demonstrate a HGF-induced proliferation of adult human pancreatic 3-cells. Irrespective of the presence of HGF and/or the 804G matrix, (3-cells exhibited an extremely low proliferative activity in vitro. Less than 0.1% of p-cells were found to be BrdU + , confirming previous reports on the negligible mitotic potential of differentiated human (3-cells, both in vitro (4) and in vivo (9). (arrows) covering an a-(2?) (4800x) or p-cell (F) (19,200x) . Data are means ± SE. *BrdU was added 24 h before analysis, medium containing 11.1 mmol/1 glucose. tP < 0.01 vs. suspensions and P < 0.05 vs. matrix.
